Indeed, Nrf2 expression has been associated with tumour-cell resistance to cisplatin [6] while Nrf2 inhibitors can sensitize various cancer cell lines and xenografts to cisplatin [4,108]. The gene discussed is NFE2L2; the disease is cancer.